Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Orgenesis's annualizedGross Profit for the quarter that ended in Dec. 2021 was $-5.87 Mil.
Orgenesis's average Total Assets over the quarter that ended in Dec. 2021 was $62.52 Mil. Therefore, Orgenesis's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2021 was -9.39%.
Orgenesis Gross-Profit-to-Asset % Historical Data
The historical data trend for Orgenesis's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Orgenesis Annual Data
Trend
Nov12
Nov13
Nov14
Nov15
Nov16
Nov17
Nov18
Dec19
Dec20
Dec21
Gross-Profit-to-Asset %
8.95
13.80
-9.84
-26.99
10.68
Orgenesis Quarterly Data
Feb17
May17
Aug17
Nov17
Feb18
May18
Aug18
Nov18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Gross-Profit-to-Asset %
-8.10
21.22
15.32
8.82
-9.39
Competitive Comparison
For the Biotechnology subindustry, Orgenesis's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orgenesis Gross-Profit-to-Asset % Distribution
For the Biotechnology industry and Healthcare sector, Orgenesis's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Orgenesis's Gross-Profit-to-Asset % falls into.
Orgenesis Gross-Profit-to-Asset % Calculation
Orgenesis's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2021) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Orgenesis Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Orgenesis's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.25(11.9%) Volume: 130,273 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:ORGS has been successfully added to your 
